Entresto and Gallium ga 68 edotreotide drug interactions - a phase IV clinical study of FDA data
Summary:
We study 126,626 people who take Entresto (sacubitril; valsartan) and Gallium ga 68 edotreotide (gallium ga-68 edotreotide). There is no drug interaction reported.
The study analyzes what interactions people have when they take Entresto and Gallium ga 68 edotreotide. It is created by eHealthMe based on reports the from the FDA, and is updated regularly.
What is Entresto?
Entresto has active ingredients of sacubitril; valsartan. eHealthMe is studying from 126,626 Entresto users. Check the latest studies of Entresto.
What is Gallium ga 68 edotreotide?
Gallium ga 68 edotreotide has active ingredients of gallium ga-68 edotreotide.
No report is found.
Do you take Entresto and Gallium ga 68 edotreotide?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Entresto (126,626 reports)
- Gallium ga 68 edotreotide
How the study uses the data?
The study uses data from the FDA. It is based on sacubitril; valsartan and gallium ga-68 edotreotide (the active ingredients of Entresto and Gallium ga 68 edotreotide, respectively), and Entresto and Gallium ga 68 edotreotide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Bosulif cause Muscle Tightness? - 11 seconds ago
- Could Ilevro cause Uveitis? - 13 seconds ago
- Drug interactions of Apple Cider Vinegar and Linzess - 13 seconds ago
- Drug interactions of Ezetimibe and Tafinlar - 16 seconds ago
- Dalfampridine and Common Peroneal Nerve Dysfunction for Women aged 40-49 - 17 seconds ago
- Dalfampridine and Peroneal Nerve Palsy for Women aged 40-49 - 17 seconds ago
- Dalfampridine and Neuropathy - Common Peroneal Nerve for Women aged 40-49 - 17 seconds ago
- Dalfampridine and Peroneal Nerve Injury for Women aged 40-49 - 18 seconds ago
- Could Actemra cause Exposure To Communicable Disease? - 27 seconds ago
- Flonase vs. Qnasl, side effect and effectiveness comparison - 28 seconds ago